For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Stories of symptoms and symptoms of stories
+Summer Hiatus
In print
Stories of symptoms and symptoms of stories
Thursday 6 January 2022, 08:00 AM

We are on our summer break and the editorial office is closed until 17 January. In the meantime, please enjoy our Summer Hiatus series, an eclectic mix from our news and clinical archives and articles from The Conversation throughout the year. This article was first published in the 31 March edition
JUST WONDERING
Lucy O’Hagan knows symptoms can tell a story and sometimes the story is hard to hear
In general practice we see many people who have “symptoms without pathology” and they challenge us. We say these patients have somatisation, medicall
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.